je.st
news
Home › biocryst
Tag: biocryst
BioCryst Pharmaceuticals Rating Lowered to Neutral at Zacks
2013-02-08 05:07:24| Biotech - Topix.net
They currently have a $2.00 price target on the stock. A number of other analysts have also recently weighed in on BCRX.
Tags: rating
neutral
lowered
pharmaceuticals